Literature DB >> 4060922

Evaluation of a rapid, reliable, and inexpensive screening test for the serological diagnosis of human brucellosis.

M Altwegg, E Bohl.   

Abstract

In many laboratories the serological diagnosis of brucellosis is based on a tube agglutination test requiring incubation for two days and therefore causing delay in reporting of results. A slide agglutination test using an acidified, rose Bengal colored antigen that can be read after only 4 min was evaluated for its usefulness as a screening test for the presence of agglutinins in human sera. In sera of patients with culturally proven brucellosis or serological evidence for active infection the sensitivity of the slide agglutination test was 100%. Of 97 tube agglutination-negative sera none was positive in the slide test. From these results it was concluded that sera can be tested by the slide agglutination test which is quicker, easier to perform, and less expensive than the tube agglutination test. If positive, it is followed by a tube agglutination test which gives quantitative information and is necessary to follow the course of an infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4060922     DOI: 10.1016/s0176-6724(85)80099-7

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  3 in total

1.  Seropositivity in animals and risk of occupational brucellosis among abattoirs personnel associated with poor work practices and absence of safety policy in Egypt.

Authors:  Amira M Zakaria; Salwa F Ahmed; Mohamed S Motawae
Journal:  Int J Occup Environ Health       Date:  2018-09-17

2.  Comparison of a dipstick assay for detection of Brucella-specific immunoglobulin M antibodies with other tests for serodiagnosis of human brucellosis.

Authors:  Encarnación Clavijo; Ramón Díaz; Angel Anguita; Antonio García; Alfonso Pinedo; Henk L Smits
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

3.  Diagnosis of recent and relapsed cases of human brucellosis by PCR assay.

Authors:  Laila F Nimri
Journal:  BMC Infect Dis       Date:  2003-04-28       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.